PMC3263251_01
At presentation. (a) Color fundus photograph of the left eye reveals subretinal altered hemorrhages and mounds of sub-RPE hemorrhage (arrowheads) in the temporal periphery. (b) Indocyanine green angiography reveals multiple, peripheral, discrete, hyperfluorescent, polypoidal lesions (arrows) at the choroidal level, suggestive of idiopathic polypoidal choroidal vasculopathy
IJO-60-60-g001.jpg
PMC3263251_01_IJO-60-60-g001.jpg
F1
Temporal periphery of the left eye revealed subretinal exudation with altered subretinal hemorrhage and subretinal pigment epithelium (RPE) hemorrhage [Fig. 1]. However, ICGA revealed the presence of multiple hyperfluorescent polypoidal lesions in the temporal periphery at the choroidal level, suggestive of PCV [Fig. 1].
Six weeks after second bevacizumab injection. Color fundus montage (a) shows consolidation of hard exudates and reduction in the sub-RPE mounds of hemorrhages in the temporal periphery (arrow). Indocyanine green angiography (b) reveals persistent polyps (arrows)
IJO-60-60-g002.jpg
PMC3263251_01_IJO-60-60-g002.jpg
F2
ICGA showed persistent leakage from the peripheral polyps in the left eye [Fig. 2]. ICGA-guided laser photocoagulation was done to the peripheral polyps with a slit-lamp laser delivery system.
Two months after laser photocoagulation. (a) Color fundus photograph of the left eye reveals significantly reduced subretinal altered hemorrhages (arrowheads). Laser photocoagulation marks are seen in the area treated (arrow). (b) Indocyanine green angiography shows no leak from the area of treated polyps
IJO-60-60-g003.jpg
PMC3263251_01_IJO-60-60-g003.jpg
F3
Two months later, her clinical condition further improved and ICGA showed no evidence of any active polyp in the left eye [Fig. 3].
At 27 months follow-up, color fundus photograph of the left eye reveals "water-mark" area of RPE atrophy (right pointing arrows) and a subretinal scar (left pointing arrows)
IJO-60-60-g004.jpg
PMC3263251_01_IJO-60-60-g004.jpg
F4
At the last review, 27 months after laser treatment, her BCVA was 20/30 in both eyes [Fig. 4].